American Century Companies’s Adverum Biotechnologies ADVM Stock Holding History

American Century Companies’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,670	Closed	-$22.9K	–	2781
2025 Q2	$22.9K	Sell	10,670 -6,977	-40%	-$19.5K	﹤0.01%	2846
2025 Q1	$77.1K	Buy	17,647 +1,370	+8%	+$6.17K	﹤0.01%	2844
2024 Q4	$76K	Buy	16,277 +4,362	+37%	+$29.4K	﹤0.01%	2855
2024 Q3	$83.6K	Buy	+11,915	New	+$86.5K	﹤0.01%	2845
2024 Q1	–	Sell	-1,306	Closed	-$9.83K	–	2925
2023 Q4	$9.83K	Hold	1,306	–	–	﹤0.01%	2875
2023 Q3	$19.6K	Buy	+1,306	New	+$23.4K	﹤0.01%	2837

Other funds holding ADVM

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PWA

Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

American Century Companies's ADVM Position: Q3 2025 in Review

American Century Companies sold out of Adverum Biotechnologies (ADVM) in Q3 2025, closing a stake of 10,670 shares — an estimated $22.9K sold.

American Century Companies first reported a position in ADVM in Q3 2023 and held it in 6 quarters. The position peaked at $83.6K in Q3 2024. 50 funds tracked by Wall St. Rank hold ADVM as of Q3 2025.

American Century Companies reported no remaining Adverum Biotechnologies position as of Q3 2025 after selling out during the quarter.
American Century Companies sold 10,670 Adverum Biotechnologies shares in Q3 2025, an estimated $22.9K.
American Century Companies first reported a position in Adverum Biotechnologies in Q3 2023 and held it in 6 quarters.
American Century Companies's Adverum Biotechnologies position peaked at $83.6K in Q3 2024.
50 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.